Multicasting in WDM networks with heterogeneous group weights

2004 ◽  
Vol 3 (7) ◽  
pp. 534
Author(s):  
Jingyi He ◽  
Danny H. K. Tsang ◽  
S.-H. Gary Chan
Keyword(s):  
Wdm Networks ◽  
Heterogeneous Group ◽  
Group Weights

Ectodermal Dysplasia in two siblings: A Case report.

2019 ◽  
Author(s):  
CHAITHRA KALKUR ◽  
NILOFER HALIM ◽  
ANUSHA RANGARE ◽  
Rumisha .
Keyword(s):  
Case Report ◽  
Key Words ◽  
Clinical Features ◽  
Ectodermal Dysplasia ◽  
Heterogeneous Group ◽  
Eccrine Glands ◽  
Key Words Ectodermal Dysplasia

Ectodermal dysplasia is a heterogeneous group of inherited disorder affecting two or more ectodermally derived tissues such as skin, hair, nails, eccrine glands and teeth. The disorder is of two types: Hypohydrotic ectodermal dysplasia/Christ seimens –Touraine syndrome and Hydrotic ectodermal dysplasia/clousten syndrome. Commonly associated signs include hypohidrosis, anomalous dentition, onychodysplasia, hypotrichosis. Multidisciplinary approaches are required for optimal treatment3. Here, we present two cases of 19 and 13 year old male siblings who were diagnosed with the disorder based upon their clinical features. Key Words: ectodermal dysplasia, hypodontia; anomalous dentition.

Pre-Adjustment Rerouting for Wavelength Defragmentation in Optical Transparent WDM Networks

2015 ◽  
Vol E98.B (10) ◽  
pp. 2014-2021
Author(s):  
Akihiro KADOHATA ◽  
Atsushi WATANABE ◽  
Akira HIRANO ◽  
Hiroshi HASEGAWA ◽  
Ken-ichi SATO
Keyword(s):  
Wdm Networks

Minimizing Cost Grooming Policy for Static Traffic in WDM Networks

2011 ◽  
Vol 30 (9) ◽  
pp. 2242-2245
Author(s):  
Hua-xiong Yao ◽  
Zong-kai Yang
Keyword(s):  
Wdm Networks

Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders

2019 ◽  
Vol 25 (39) ◽  
pp. 5327-5346 ◽  
Author(s):  
Konstantin P. Volcho ◽  
Sergey S. Laev ◽  
Ghulam Md Ashraf ◽  
Gjumrakch Aliev ◽  
Nariman F. Salakhutdinov
Keyword(s):  
Alzheimer’S Disease ◽  
Clinical Trials ◽  
Huntington's Disease ◽  
Neurodegenerative Disorders ◽  
Heterogeneous Group ◽  
Neuroprotective Activity ◽  
Severe Loss ◽  
Neurotrophic Activity ◽  
Full Proof ◽  
Effective Treatments

Neurodegenerative disorders (NDDs) like Alzheimer's disease, Parkinson’s disease and Huntington’s disease are a heterogeneous group of disorders with the progressive and severe loss of neurons. There are no full proof cures for these diseases, and only medicines are available that can alleviate some of the symptoms. Developing effective treatments for the NDDs is a difficult but necessary task. Hence, the investigation of monoterpenoids which modulate targets applicable to many NDDs is highly relevant. Many monoterpenoids have demonstrated promising neuroprotective activity mediated by various systems. It can form the basis for elaboration of agents which will be useful both for the alleviation of symptoms of NDDs and for the treatment of diseases progression and also for prevention of neurodegeneration. The further developments including detections of monoterpenoids and their derivatives with high neuroprotective or neurotrophic activity as well as the results of qualified clinical trials are needed to draw solid conclusions regarding the efficacy of these agents.

Bi-directional add∕drop amplifier module for high-capacity WDM networks

2002 ◽  
Vol 38 (21) ◽  
pp. 1267 ◽  
Author(s):  
Hyun Deok Kim ◽  
Jeong-Hun Shin ◽  
Chang-Hee Lee
Keyword(s):  
High Capacity ◽  
Wdm Networks
Sign in / Sign up

Export Citation Format

Share Document